Skip to main content
Top
Published in: Diabetology International 3/2022

05-01-2022 | Insulins | Original Article

Illness perception, medication adherence and glycemic control among primary health-care patients with type 2 diabetes mellitus at Port Said City, Egypt

Authors: Rabab Atta Saudi, Rokaia Atef Abbas, Hebatallah Nour-Eldein, Hazem A. Sayed Ahmed

Published in: Diabetology International | Issue 3/2022

Login to get access

Abstract

Aims

Despite the availability of a wide selection of antidiabetic treatments, many patients with type 2 diabetes mellitus (T2DM) still do not have controlled glucose levels. This study aimed to assess illness perception, medication adherence, and glycemic control among primary care attendees with T2DM.

Methods

A cross-sectional study was conducted between July 2019 and November 2020. A random sample of 265 Egyptian T2DM patients were enrolled from primary health-care settings in Port Said, Egypt. Data on socio-demographic characteristics, lifestyle habits, and diabetic medical history were collected using a semi-structured questionnaire. The Brief Illness Perception Questionnaire (B-IPQ) was used to assess diabetes perception, whereas the 8-item Morisky Medication Adherence Scale (MMAS-8) was used to investigate medication adherence.

Results

There was a significant difference in B-IPQ scores between different groups of the patients in terms of diabetic medications, complications, and glycemic control (p < 0.05). There was a significant difference in MMAS-8 score found between different groups of the patients in terms of disease duration, family history of T2DM, and glycemic control (p < 0.05). Further, there was a significant difference in HbA1c score found between different groups of patients in terms of disease duration, medications, complications, and family history of T2DM (p < 0.05). Higher BMI, a positive family history of T2DM, patients who take insulin, high illness perception, and poor medication adherence were the factors associated with higher HbA1c level.

Conclusion

Higher HbA1c levels were linked to a higher BMI, a positive family history of T2DM, insulin users, high illness perception, and poor medication adherence.
Literature
1.
4.
go back to reference Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm. 2014;36(3):488–97.CrossRefPubMed Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm. 2014;36(3):488–97.CrossRefPubMed
5.
go back to reference Melzer AC, Uman J, Au DH. Adherence to oral medications for hypertension and diabetes in veterans with comorbid airflow limitation. Ann Am Thorac Soc. 2015;6(12):831–7.CrossRef Melzer AC, Uman J, Au DH. Adherence to oral medications for hypertension and diabetes in veterans with comorbid airflow limitation. Ann Am Thorac Soc. 2015;6(12):831–7.CrossRef
7.
go back to reference van Puffelen AL, Heijmans MJWM, Rijken M, et al. Illness perceptions and self-care behaviours in the first years of living with type 2 diabetes; does the presence of complications matter? Psychol Health. 2015;30(11):1274–87.CrossRefPubMed van Puffelen AL, Heijmans MJWM, Rijken M, et al. Illness perceptions and self-care behaviours in the first years of living with type 2 diabetes; does the presence of complications matter? Psychol Health. 2015;30(11):1274–87.CrossRefPubMed
11.
go back to reference Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3):S3-14.CrossRefPubMedPubMedCentral Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3):S3-14.CrossRefPubMedPubMedCentral
12.
go back to reference Radwan M, Elsous A, Al-Sharif H, et al. Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine. Ther Adv Endocrinol Metab. 2017;9(1):3–14.CrossRefPubMedPubMedCentral Radwan M, Elsous A, Al-Sharif H, et al. Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine. Ther Adv Endocrinol Metab. 2017;9(1):3–14.CrossRefPubMedPubMedCentral
13.
go back to reference Saarti S, Jabbour H, El Osta N, et al. Cross-cultural adaptation and psychometric properties of an Arabic language version of the brief illness perception questionnaire in Lebanon. Libyan J Med. 2016;11:31976.CrossRefPubMed Saarti S, Jabbour H, El Osta N, et al. Cross-cultural adaptation and psychometric properties of an Arabic language version of the brief illness perception questionnaire in Lebanon. Libyan J Med. 2016;11:31976.CrossRefPubMed
14.
go back to reference Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:34854.CrossRef Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:34854.CrossRef
15.
go back to reference Ashur ST, Shah SA, Bosseri S, et al. Illness perceptions of libyans with T2DM and their influence on medication adherence: a study in a diabetes center in tripoli. Libyan J Med. 2015;10:29797.CrossRefPubMed Ashur ST, Shah SA, Bosseri S, et al. Illness perceptions of libyans with T2DM and their influence on medication adherence: a study in a diabetes center in tripoli. Libyan J Med. 2015;10:29797.CrossRefPubMed
17.
go back to reference Petricek G, Vrcic-Keglevic M, Vuletic G, et al. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. Croat Med J. 2009;50(6):583–93.CrossRefPubMedPubMedCentral Petricek G, Vrcic-Keglevic M, Vuletic G, et al. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. Croat Med J. 2009;50(6):583–93.CrossRefPubMedPubMedCentral
18.
go back to reference Alyami M, Serlachius A, Mokhtar I, et al. Illness perceptions, HbA1c, and adherence in type 2 diabetes in Saudi Arabia. Patient Prefer Adherence. 2019;13:1839–50.CrossRefPubMedPubMedCentral Alyami M, Serlachius A, Mokhtar I, et al. Illness perceptions, HbA1c, and adherence in type 2 diabetes in Saudi Arabia. Patient Prefer Adherence. 2019;13:1839–50.CrossRefPubMedPubMedCentral
19.
go back to reference Lee SF, Teh XR, Malar LS, et al. The associations of illness perception with metabolic control (HbA1c) among type 2 diabetes mellitus patients in a district hospital. Int J Pharm Pract. 2018;26:442–9.CrossRefPubMed Lee SF, Teh XR, Malar LS, et al. The associations of illness perception with metabolic control (HbA1c) among type 2 diabetes mellitus patients in a district hospital. Int J Pharm Pract. 2018;26:442–9.CrossRefPubMed
20.
go back to reference Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.CrossRefPubMed Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.CrossRefPubMed
21.
go back to reference Jaam M, Ibrahim MIM, Kheir N, et al. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: a systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1–15.CrossRefPubMed Jaam M, Ibrahim MIM, Kheir N, et al. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: a systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1–15.CrossRefPubMed
22.
go back to reference Heissam K, Abuamer Z, El-Dahshan N. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study. Pan Afr Med J. 2015;20:177.CrossRefPubMedPubMedCentral Heissam K, Abuamer Z, El-Dahshan N. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study. Pan Afr Med J. 2015;20:177.CrossRefPubMedPubMedCentral
23.
go back to reference Hashimoto K, Urata K, Yoshida A, et al. The relationship between patients’ perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan. J Pharm Health Care Sci. 2019;5:2.CrossRefPubMedPubMedCentral Hashimoto K, Urata K, Yoshida A, et al. The relationship between patients’ perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan. J Pharm Health Care Sci. 2019;5:2.CrossRefPubMedPubMedCentral
24.
go back to reference Levinger I, Selig S, Jerums G, et al. Depressed mood, glycaemic control and functional capacity in overweight/obese men with and without type 2 diabetes. Diabetol Metab Syndr. 2012;4(1):46.CrossRefPubMedPubMedCentral Levinger I, Selig S, Jerums G, et al. Depressed mood, glycaemic control and functional capacity in overweight/obese men with and without type 2 diabetes. Diabetol Metab Syndr. 2012;4(1):46.CrossRefPubMedPubMedCentral
25.
go back to reference Mahmood MI, Daud F, Ismail A. Glycaemic control and associated factors among patients with diabetes at public health clinics in Johor, Malaysia. Public Health. 2016;135:56–65.CrossRefPubMed Mahmood MI, Daud F, Ismail A. Glycaemic control and associated factors among patients with diabetes at public health clinics in Johor, Malaysia. Public Health. 2016;135:56–65.CrossRefPubMed
26.
go back to reference Alzaheb R, Altemani A. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes Targets Ther [Internet]. 2018;11:15–21.CrossRef Alzaheb R, Altemani A. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes Targets Ther [Internet]. 2018;11:15–21.CrossRef
27.
go back to reference Wong JS, Rahimah N. Glycaemic control of diabetic patients in an urban primary health care setting in Sarawak: the Tanah Puteh Health Centre experience. Med J Malaysia. 2004;59(3):411–7.PubMed Wong JS, Rahimah N. Glycaemic control of diabetic patients in an urban primary health care setting in Sarawak: the Tanah Puteh Health Centre experience. Med J Malaysia. 2004;59(3):411–7.PubMed
Metadata
Title
Illness perception, medication adherence and glycemic control among primary health-care patients with type 2 diabetes mellitus at Port Said City, Egypt
Authors
Rabab Atta Saudi
Rokaia Atef Abbas
Hebatallah Nour-Eldein
Hazem A. Sayed Ahmed
Publication date
05-01-2022
Publisher
Springer Nature Singapore
Published in
Diabetology International / Issue 3/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00567-6

Other articles of this Issue 3/2022

Diabetology International 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine